Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.

Clinical trial NCT06863467 · COMPLETED

Trial details

NCT number: NCT06863467
Sponsor: Revelation Biosciences, Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Renal Insufficiency, Chronic Chronic Kidney Disease stage3 Chronic Kidney Disease stage4

Start date: 2025-01-20
Primary completion: 2025-07-22
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.